|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
News Releases, information, etc. from the "Exelon" corporate website are green | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Saturday
Exelon:
Rivastigmine (Exelon) was approved in 2000 by the U.S. Food and Drug Administration (FDA) to treat cognitive symptoms of Alzheimer’s disease. Exelon is a cholinesterase inhibitor. Cholinesterase Inhibitors are believed to work by delaying the breakdown of acetylcholine in the brain. Acetylcholine helps communication between the nerve cells and is important for memory. |